nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

01.12.2009 | Review Article

Current trends in initial management of oropharyngeal cancer: the declining use of open surgery

verfasst von: Missak Haigentz Jr., Carl E. Silver, June Corry, Eric M. Genden, Robert P. Takes, Alessandra Rinaldo, Alfio Ferlito

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

The widespread availability of novel primary treatment approaches against oropharyngeal cancers has provided several potentially curative surgical and nonsurgical treatment options for patients, generating both hope and controversy. As treatment is usually curative in intent, management considerations must include consideration of primary tumor and nodal disease control as well as long-term toxicities and functional outcomes. Anatomical and functional organ preservation (speech and deglutition) remains of paramount importance to patients with oropharyngeal cancer and the physicians involved in their care, accounting for the growing popularity of chemoradiotherapy and transoral surgical techniques for this indication. These novel approaches have greatly diminished the role of open surgery as initial therapy for oropharyngeal cancers. Open surgery which is often reserved for salvage on relapse, may still be an appropriate therapy for certain early stage primary lesions. The growing treatment armamentarium requires careful consideration for optimal individualized care. The identification of oncogenic human papillomavirus as a predictive and prognostic marker in patients with oropharyngeal cancer has great potential to further optimize the choice of treatment. In this review, novel primary therapies against oropharyngeal squamous cell carcinoma are presented in the context of anatomical, quality of life, and emerging biological considerations.

Cohan DM, Popat S, Kaplan SE, Rigual N, Loree T, Hicks WL Jr (2009) Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg 17(2):88–94CrossRefPubMed

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249CrossRefPubMed

National Cancer Institute, Surveillance, Epidemiology and End Results (SEER) Program. http://www.seer.cancer.gov/

Puscas L (2005) The role of human papilloma virus infection in the etiology of oropharyngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg 13(4):212–216CrossRefPubMed

Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P et al (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344(15):1125–1131CrossRefPubMed

Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95(23):1772–1783PubMed

D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM et al (2007) Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356(19):1944–1956CrossRefPubMed

Gillison ML (2009) Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol 21:439–444

Gillison ML, D’Souza G, Westra W, Sugar E, Xiao W, Begum S et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100(6):407–420CrossRefPubMed

10.

Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26(4):612–619CrossRefPubMed

11.

Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR et al (2004) Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96(13):998–1006PubMedCrossRef

12.

Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ et al (2007) Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 67(10):4605–4619CrossRefPubMed

13.

Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM (2008) Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 14(2):366–369CrossRefPubMed

14.

Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP et al (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104(3):336–344CrossRefPubMed

15.

Kumar B, Cordell KG, Lee JS, Prince ME, Tran HH, Wolf GT et al (2007) Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys 69(2 Suppl):S109–S111PubMed

16.

Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100(4):261–269CrossRefPubMed

17.

Klozar J, Kratochvil V, Salakova M, Smahelova J, Vesela E, Hamsikova E et al (2008) HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 265(Suppl 1):S75–S82CrossRefPubMed

18.

Hafkamp HC, Manni JJ, Haesevoets A, Voogd AC, Schepers M, Bot FJ et al (2008) Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 122(12):2656–2664CrossRefPubMed

19.

Kreeft A, Tan IB, van den Brekel MW, Hilgers FJ, Balm AJ (2009) The surgical dilemma of ‘functional inoperability’ in oral and oropharyngeal cancer: current consensus on operability with regard to functional results. Clin Otolaryngol 34(2):140–146CrossRefPubMed

20.

Cosmidis A, Rame JP, Dassonville O, Temam S, Massip F, Poissonnet G et al (2004) T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study. Eur Arch Otorhinolaryngol 261(5):276–281CrossRefPubMed

21.

Moncrieff M, Sandilla J, Clark J, Clifford A, Shannon K, Gao K et al (2009) Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx. Laryngoscope 119(2):307–311CrossRefPubMed

22.

Reddy AN, Eisele DW, Forastiere AA, Lee DJ, Westra WH, Califano JA (2005) Neck dissection followed by radiotherapy or chemoradiotherapy for small primary oropharynx carcinoma with cervical metastasis. Laryngoscope 115(7):1196–1200CrossRefPubMed

23.

Grant DG, Salassa JR, Hinni ML, Pearson BW, Perry WC (2006) Carcinoma of the tongue base treated by transoral laser microsurgery, part one: Untreated tumors, a prospective analysis of oncologic and functional outcomes. Laryngoscope 116(12):2150–2155CrossRefPubMed

24.

Rich JT, Milov S, Lewis JS, Jr, Thorstad WL, Adkins DR, Haughey BH (2009) Transoral laser microsurgery (TLM) ± adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope 119:1709–1719

25.

O’Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG (2006) Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 116(8):1465–1472CrossRefPubMed

26.

Genden EM, Desai S, Sung CK (2009) Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck 31(3):283–289CrossRefPubMed

27.

Moore EJ, Henstrom DK, Olsen KD, Kasperbauer JL, McGree ME (2009) Transoral resection of tonsillar squamous cell carcinoma. Laryngoscope 119(3):508–515CrossRefPubMed

28.

Park YM, Lee JG, Lee WS, Choi EC, Chung SM, Kim SH (2009) Feasibility of transoral lateral oropharyngectomy using a robotic surgical system for tonsillar cancer. Oral Oncol 45(8):e62–e66CrossRefPubMed

29.

Mukhija VK, Sung CK, Desai SC, Wanna G, Genden EM (2009) Transoral robotic assisted free flap reconstruction. Otolaryngol Head Neck Surg 140(1):124–125CrossRefPubMed

30.

Stoeckli SJ, Alkureishi LW, Ross GL (2009) Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 266(6):787–793CrossRefPubMed

31.

Chao KS, Majhail N, Huang CJ, Simpson JR, Perez CA, Haughey B et al (2001) Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 61(3):275–280CrossRefPubMed

32.

Chao KS, Ozyigit G, Blanco AI, Thorstad WL, Deasy JO, Haughey BH et al (2004) Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 59(1):43–50PubMed

33.

de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M et al (2006) Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64(2):363–373PubMed

34.

Yao M, Nguyen T, Buatti JM, Dornfeld KJ, Tan H, Wacha J et al (2006) Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol 29(6):606–612CrossRefPubMed

35.

Daly ME, Le QT, Maxim PG, Loo BW Jr, Kaplan MJ, Fischbein NJ et al (2009) Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys [Epub ahead of print]

36.

Lawson JD, Otto K, Chen A, Shin DM, Davis L, Johnstone PA (2008) Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base. Head Neck 30(3):327–335CrossRefPubMed

37.

Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C (2008) Effect of radiation techniques in treatment of oropharynx cancer. Laryngoscope 118(4):635–639CrossRefPubMed

38.

Lee NY, de Arruda FF, Puri DR, Wolden SL, Narayana A, Mechalakos J et al (2006) A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66(4):966–974PubMed

39.

Garden AS, Morrison WH, Wong PF, Tung SS, Rosenthal DI, Dong L et al (2007) Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67(2):438–444PubMed

40.

Eisbruch A, Harris J, Garden AS, Chao CK, Straube W, Harari PM, et al (2009) Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys [Epub ahead of print]

41.

Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48(1):7–16CrossRefPubMed

42.

Horiot JC, Le Fur R, N’Guyen T, Chenal C, Schraub S, Alfonsi S et al (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25(4):231–241CrossRefPubMed

43.

Goffinet DR, Fee WE Jr, Wells J, Austin-Seymour M, Clarke D, Mariscal JM et al (1985) 192Ir pharyngoepiglottic fold interstitial implants. The key to successful treatment of base tongue carcinoma by radiation therapy. Cancer 55(5):941–948CrossRefPubMed

44.

Housset M, Baillet F, Dessard-Diana B, Martin D, Miglianico L (1987) A retrospective study of three treatment techniques for T1–T2 base of tongue lesions: surgery plus postoperative radiation, external radiation plus interstitial implantation and external radiation alone. Int J Radiat Oncol Biol Phys 13(4):511–516PubMed

45.

Leborgne JH, Leborgne F, Barlocci LA, Ortega B (1986) The place of brachytherapy in the treatment of carcinoma of the tonsil with lingual extension. Int J Radiat Oncol Biol Phys 12(10):1787–1792PubMed

46.

Esche BA, Haie CM, Gerbaulet AP, Eschwege F, Richard JM, Chassagne D (1988) Interstitial and external radiotherapy in carcinoma of the soft palate and uvula. Int J Radiat Oncol Biol Phys 15(3):619–625PubMed

47.

Pernot M, Malissard L, Taghian A, Hoffstetter S, Luporsi E, Forcard JJ et al (1992) Velotonsillar squamous cell carcinoma: 277 cases treated by combined external irradiation and brachytherapy—results according to extension, localization, and dose rate. Int J Radiat Oncol Biol Phys 23(4):715–723PubMed

48.

Mazeron JJ, Belkacemi Y, Simon JM, Le Pechoux C, Martin M, Haddad E et al (1993) Place of Iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas. Int J Radiat Oncol Biol Phys 27(2):251–257PubMed

49.

Levendag PC, Schmitz PI, Jansen PP, Senan S, Eijkenboom WM, Sipkema D et al (1997) Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 38(3):497–506PubMed

50.

Rudoltz MS, Perkins RS, Luthmann RW, Fracke TD, Green TM, Moye L et al (1999) High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx. Laryngoscope 109(12):1967–1973CrossRefPubMed

51.

Quon H, Harrison LB (2002) Brachytherapy in the treatment of head and neck cancer. Oncology (Williston Park) 16(10):1379–1393; discussion 1393, 1395–1376

52.

Mazeron JJ, Ardiet JM, Haie-Meder C, Kovacs G, Levendag P, Peiffert D et al (2009) GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 91(2):150–156CrossRefPubMed

53.

Chen J, Pappas L, Moeller JH, Rankin J, Sharma PK, Bentz BG et al (2007) Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck 29(4):362–369CrossRefPubMed

54.

Forastiere AA (2008) Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol 97(8):701–707CrossRefPubMed

55.

Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P et al (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91(24):2081–2086CrossRefPubMed

56.

Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T et al (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22(1):69–76CrossRefPubMed

57.

Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H et al (2007) Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 25(25):3971–3977CrossRefPubMed

58.

Posner M, Vermorken JB (2008) Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer. Semin Oncol 35(3):221–228CrossRefPubMed

59.

Huang SM, Bock JM, Harari PM (1999) Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 59(8):1935–1940PubMed

60.

Robert F, Ezekiel MP, Spencer SA, Meredith RF, Bonner JA, Khazaeli MB et al (2001) Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 19(13):3234–3243PubMed

61.

Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578CrossRefPubMed

62.

Curran D, Giralt J, Harari PM, Ang KK, Cohen RB, Kies MS et al (2007) Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 25(16):2191–2197CrossRefPubMed

63.

Holsinger FC, Lin HY, Bassot V, Laccourreye O (2009) Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx. Cancer 115:3909–3918

64.

Holsinger FC, Kies MS, Diaz EM, Jr, Gillenwater AM, Lewin JS, Ginsberg LE et al (2009) Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol 27:1976–1982

65.

Laccourreye O, Hans S, Menard M, Garcia D, Brasnu D, Holsinger FC (2005) Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence. Arch Otolaryngol Head Neck Surg 131(7):592–599CrossRefPubMed

66.

Parsons JT, Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Villaret DB et al (2002) Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 94(11):2967–2980CrossRefPubMed

67.

Mowry SE, Ho A, Lotempio MM, Sadeghi A, Blackwell KE, Wang MB (2006) Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope 116(9):1589–1593CrossRefPubMed

68.

Allal AS, Nicoucar K, Mach N, Dulguerov P (2003) Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck 25(10):833–839; discussion 839–840

69.

Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T et al (2003) Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 55(1):93–98CrossRefPubMed

70.

Ferlito A, Corry J, Silver CE, Shaha AR, Thomas Robbins K, Rinaldo A (2009) Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck [Epub ahead of print]

71.

Yao M, Buatti JM, Dornfeld KJ, Graham MM, Smith RB, Funk GF et al (2005) Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In regard to Rogers et al. (Int J Radiat Oncol Biol Phys. 2004;58:694–697). Int J Radiat Oncol Biol Phys 61(1):306–307; author reply 307

72.

Brkovich VS, Miller FR, Karnad AB, Hussey DH, McGuff HS, Otto RA (2006) The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 116(6):855–858CrossRefPubMed

73.

Winter H, Meimarakis G, Hoffmann G, Hummel M, Ruttinger D, Zilbauer A et al (2008) Does surgical resection of pulmonary metastases of head and neck cancer improve survival? Ann Surg Oncol 15(10):2915–2926CrossRefPubMed

74.

Liu D, Labow DM, Dang N, Martini N, Bains M, Burt M et al (1999) Pulmonary metastasectomy for head and neck cancers. Ann Surg Oncol 6(6):572–578CrossRefPubMed

75.

Wedman J, Balm AJ, Hart AA, Loftus BM, Hilgers FJ, Gregor RT et al (1996) Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck 18(4):311–316CrossRefPubMed

76.

Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359(11):1116–1127CrossRefPubMed

77.

Lee SC, Shores CG, Weissler MC (2008) Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg 16(2):135–140CrossRefPubMed

78.

Goodwin WJ, Jr (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110(3 Pt 2 Suppl 93):1–18

79.

Pradhan SA, Rajpal RM, Kothary PM (1980) Surgical management of postradiation residual/recurrent cancer of the base of the tongue. J Surg Oncol 14(3):201–206CrossRefPubMed

80.

Rodriguez R, Perry C, Soo KC, Shaw HJ (1987) Total glossectomy. Am J Surg 154(4):415–418CrossRefPubMed

81.

Barry B, Baujat B, Albert S, Nallet E, Depondt J, Guedon C et al (2003) Total glossectomy without laryngectomy as first-line or salvage therapy. Laryngoscope 113(2):373–376CrossRefPubMed

82.

Grant DG, Salassa JR, Hinni ML, Pearson BW, Perry WC (2006) Carcinoma of the tongue base treated by transoral laser microsurgery, part two: Persistent, recurrent and second primary tumors. Laryngoscope 116(12):2156–2161CrossRefPubMed

83.

Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC (2008) Transoral laser microsurgery for recurrent laryngeal and pharyngeal cancer. Otolaryngol Head Neck Surg 138(5):606–613CrossRefPubMed

84.

Regueiro CA, de la Torre A, Valcarcel FJ, Magallon R, Aragon G (1995) Salvage brachytherapy and salvage surgery for recurrent oropharyngeal carcinoma following radiotherapy. J Laryngol Otol 109(1):45–48CrossRefPubMed

85.

Copper MP, Triesscheijn M, Tan IB, Ruevekamp MC, Stewart FA (2007) Photodynamic therapy in the treatment of multiple primary tumours in the head and neck, located to the oral cavity and oropharynx. Clin Otolaryngol 32(3):185–189CrossRefPubMed

Titel: Current trends in initial management of oropharyngeal cancer: the declining use of open surgery
verfasst von: Missak Haigentz Jr.
Carl E. Silver
June Corry
Eric M. Genden
Robert P. Takes
Alessandra Rinaldo
Alfio Ferlito
Publikationsdatum: 01.12.2009
Verlag: Springer-Verlag
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 12/2009
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-009-1109-2

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Current trends in initial management of oropharyngeal cancer: the declining use of open surgery

Abstract

Neu im Fachgebiet HNO

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Akuter Schwindel: Wann lohnt sich eine MRT?

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2009

Image evaluation of endolymphatic space in fluctuating hearing loss without vertigo

Investigation of the synergism between alcohol consumption and herpes simplex virus in patients with laryngeal squamous cell cancers

The effects of phototherapy on quality of life in allergic rhinitis cases

CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma

Correlation of orbital dysmorphisms with nasal polyposis: a clinical study

Pseudohypacusis: the most frequent etiology of sudden hearing loss in children

Neu im Fachgebiet HNO

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Akuter Schwindel: Wann lohnt sich eine MRT?

Update HNO